Fusion Pharmaceuticals Inc (FUSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 2,068 | 1,461 | 1,440 | 0 | 0 |
| Gross Profit | 2,068 | 1,461 | 1,440 | N/A | N/A |
| Operating Expenses | 101,300 | 89,495 | 83,455 | 37,935 | 18,220 |
| Operating Income | -99,232 | -88,034 | -82,015 | -37,935 | -18,220 |
| Other Income | 5,122 | -1,415 | 850 | -37,787 | 2,282 |
| Pre-tax Income | -94,110 | -89,449 | -81,165 | -75,722 | -15,938 |
| Income Tax | 787 | -1,837 | -118 | 2,611 | 251 |
| Net Income Continuous | -94,897 | -87,612 | -81,047 | -78,333 | -16,189 |
| Net Income | $-94,897 | $-87,612 | $-81,047 | $-78,333 | $-16,189 |
| EPS Basic Total Ops | -1.45 | -2.00 | -1.90 | -3.62 | -8.45 |
| EPS Basic Continuous Ops | -1.45 | -2.00 | -1.90 | -3.56 | -8.45 |
| EPS Diluted Total Ops | -1.45 | -2.00 | -1.90 | -3.62 | -8.45 |
| EPS Diluted Continuous Ops | -1.45 | -2.00 | -1.90 | -3.56 | -8.45 |
| EPS Diluted Before Non-Recurring Items | -1.45 | -2.00 | -1.90 | -1.84 | N/A |
| EBITDA(a) | $-97,887 | $-87,125 | $-81,381 | $-37,453 | $-17,930 |